Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine;Przewlekłe zapalenie watroby typu B leczone Peg-IFN alfa-2a w monoterapii lub skojarzeniu z lamiwudyna--wyniki obserwacji długoterminowej.

Przegla̧d epidemiologiczny

Volumn 61, Issue 3, 2007, Pages 433-437

  Pogorzelska, Joanna ^a   Flisiak, Robert ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DRUG COMBINATION; DRUG EFFECT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; REVIEW; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A; LAMIVUDINE; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 38749144033     PISSN: 00332100     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)